2 months ago
CSTL
AnalystsPaul KnightPaul Knight's Stock Forecasts
AnalystsPaul Knight
Analyst Ranking
Top 23%
#1023 out of 4554 analysts
Average Return
+2.31%
Win Rate
46%52 out of 112
Risk vs Reward
Poor
Good
Paul Knight's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avid Bioservices IncCDMO | +303.75% | $8.26 | $33.35 | 2020-11-09 - 2021-11-09 | Strong Buy |
Cryoport IncCYRX | +186.11% | $5.47 | $15.65 | 2017-07-11 - 2018-07-12 | Strong Buy |
Oncocyte CorpOCX | +110.59% | $34.00 | $71.60 | 2020-11-09 - 2021-11-09 | Strong Buy |
Azenta IncAZTA | +107.18% | $59.43 | $123.13 | 2020-11-09 - 2021-11-09 | Strong Buy |
Harvard Bioscience IncHBIO | +95.38% | $3.90 | $7.62 | 2020-11-09 - 2021-11-09 | Strong Buy |
Paul Knight Analyst Color
Get additional color on Paul Knight's coverage of popular stocks
2 months ago
RGEN
2 months ago
WST
8 months ago
WST
8 months ago
WST
Paul Knight's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Castle Biosciences IncCSTL | 6 | Strong Buy | $28.00 | +45.83% | Maintains | 2 months ago |
Repligen CorpRGEN | 7 | Strong Buy | $220.00 | +40.07% | Maintains | 2 months ago |
West Pharmaceutical Services IncWST | 10 | Strong Buy | $470.00 | +24.56% | Maintains | 2 months ago |
Revvity IncRVTY | 6 | Strong Buy | $126.00 | +26.79% | Maintains | 3 months ago |
Danaher CorpDHR | 7 | Strong Buy | $290.00 | +22.69% | Maintains | 3 months ago |
Avid Bioservices IncCDMO | 4 | Strong Buy | $14.00 | +114.72% | Maintains | 4 months ago |
Bio Techne CorpTECH | 5 | Strong Buy | $80.00 | +28.60% | Maintains | 6 months ago |
Stevanato Group SpaSTVN | 5 | Strong Buy | $37.00 | +30.28% | Maintains | 8 months ago |
Standard Biotools IncLAB | 1 | Strong Buy | $4.00 | +57.48% | Initiates Coverage On | 9 months ago |
Thermo Fisher Scientific IncTMO | 5 | Strong Buy | $640.00 | +18.19% | Maintains | a year ago |
Harvard Bioscience IncHBIO | 4 | Strong Buy | $7.00 | +76.32% | Maintains | a year ago |
Maravai Lifesciences Holdings IncMRVI | 7 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Cryoport IncCYRX | 6 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Agilent Technologies IncA | 6 | Strong Buy | $165.00 | N/A | Maintains | a year ago |
Telesis Bio IncTBIO | 3 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Catalent IncCTLT | 4 | Strong Buy | $85.00 | N/A | Maintains | a year ago |
Azenta IncAZTA | 8 | Strong Buy | $70.00 | N/A | Maintains | a year ago |
Avantor IncAVTR | 5 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Exagen IncXGN | 5 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Biolife Solutions IncBLFS | 3 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Charles River Laboratories International IncCRL | 1 | Strong Buy | $300.00 | N/A | Maintains | 2 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $250.00 | N/A | Maintains | 2 years ago |
Phenomex IncCELL | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Teleflex IncTFX | 1 | Strong Buy | $441.00 | N/A | Maintains | 3 years ago |
Icu Medical IncICUI | 1 | Strong Buy | $236.00 | N/A | Maintains | 3 years ago |
Cooper Companies IncCOO | 1 | Strong Buy | $99.00 | N/A | Maintains | 3 years ago |
Avanos Medical IncAVNS | 1 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Waters CorpWAT | 3 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Veracyte IncVCYT | 3 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Oncocyte CorpOCX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Mesa Laboratories IncMLAB | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Illumina IncILMN | 1 | Hold | N/A | N/A | Upgrades | 6 years ago |
Nanostring Technologies IncNSTGQ | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Foundation Medicine IncFMI | 1 | Hold | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.